{"id":"NCT01741532","sponsor":"ApoPharma","briefTitle":"Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)","officialTitle":"A Randomized, Double-blind, Placebo-controlled Trial of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-12-13","primaryCompletion":"2016-10-21","completion":"2017-01-11","firstPosted":"2012-12-05","resultsPosted":"2019-05-23","lastUpdate":"2019-07-05"},"enrollment":89,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pantothenate Kinase-Associated Neurodegeneration"],"interventions":[{"type":"DRUG","name":"Deferiprone oral solution","otherNames":["DFP","L1"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Deferiprone","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"A multi-center, placebo controlled, double-blind trial comparing the efficacy and safety of 18 months of treatment with deferiprone versus placebo in patients with PKAN.\n\nThis investigator-initiated trial was funded by the European Commission's Seventh Framework Programme (FP7/2007-2013, HEALTH-F2-2011, grant agreement No. 277984) to the TIRCON consortium (Treat Iron-Related Childhood-Onset Neurodegeneration) and by the FDA Office of Orphan Products Development (OOPD) (Dr. Elliott Vichinsky).","primaryOutcome":{"measure":"Change in Score on Barry-Albright Dystonia Scale","timeFrame":"Baseline to 18 Months","effectByArm":[{"arm":"Deferiprone","deltaMin":2.48,"sd":0.63},{"arm":"Placebo","deltaMin":3.99,"sd":0.82}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0761"}]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":4,"countries":["United States","Germany","Italy","United Kingdom"]},"refs":{"pmids":["31202468"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":58},"commonTop":["Dystonia","Pyrexia","Serum ferritin decreased","Headache","Condition aggravated"]}}